Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic ...

There has been no halt in trading and shares are expected to continue trading unabated. This press release is for informational purposes only. It shall not constitute an offer to sell or exchange nor ...

Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Argenx Se (ARGX – Research Report) yesterday and set a price target ...

A special blood drive was held Monday afternoon to honor a Cranston High School East teacher battling leukemia.

It's hard to believe that I've now reached the 6-month point of my treatment for Chronic Myeloid Leukemia (CML) at Roswell ...

A new study evaluating the quadratic phenotypic optimization platform shows it can accurately predict personalized drug ...

Jefferies analyst Roger Song maintained a Buy rating on Kura Oncology (KURA – Research Report) on January 3 and set a price target of ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

Interesting trends were observed in the subgroup analyses of the phase 3 uproleselan study in relapsed or refractory acute ...

Investor David Lazar has come to the rescue of cash-strapped Cyclacel Pharmaceuticals, pumping $3 million into the biotech as ...

The holidays can be especially tough for cancer patients, but two best friends are making the best of it by supporting each ...

Eunice S. Wang, MD, discusses a retrospective study of 105 patients diagnosed with secondary acute myeloid leukemia.